Vietnam Investment Review on MSN9h
AIM Vaccine reduces losses by nearly 90% in 2024, with the iterative major product series opening up space for explosive growth in performanceIn the context of intensified competition in the domestic vaccine industry, AIM Vaccine's Hansen yeast recombinant hepatitis B vaccine saw an increase in sales revenue, standing firm against market ...
ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy ...
We may be overconsuming protein, but our appetite for the nutrient shows no signs of being satiated – and future food brands ...
EMA committee recommends approval of Bristol Myers Squibb’s subcutaneous formulation of Opdivo across multiple solid tumour indications: Princeton, New Jersey Monday, March 31, ...
Korea Investment CORP grew its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 362.5% ...
We recently curated a list of 11 High-Risk High-Reward Growth Stocks To Buy Now. Here, we take a detailed look at Novavax, Inc. (NASDAQ:NVAX) and its ranking among the top picks. The stock market has ...
How cardiac cell fates are specified during heart development remains elusive. This study identifies a level-dependent role ...
Single-Molecule Footprinting reveals that RNA polymerase II (Pol II) occupancy is infrequent at mouse promoters. This results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback